Infectious Disease Diagnostics Market

01

Executive Summary

Global Infectious Disease Diagnostics Market Size, 2017-2026 (USD Billion)

The global infectious disease diagnostics market size is expected to grow from USD 23.70 billion in 2020 to USD 36.67 billion by 2026 at a CAGR of 7.5%.

Market growth is driven by the global prevalence of infectious diseases & the onset of COVID-19 and the growing awareness for early disease diagnosis, the shift in focus from centralized laboratories to decentralized POC testing, and rising technological advancements.

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies but had a positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. With the COVID-19 pandemic, responding to infectious disease has become a pressing medical issue worldwide. In addition to the development of vaccines and therapeutic drugs, there is a growing call for the development of more precise and simple testing technologies and the expansion of testing structures. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers face unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities.

The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. Broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics; hence, it is expected to have a positive impact on this market.

Developing economies such as India, South Korea, Brazil, and Mexico are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.

Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2020, the reagents, kits, and consumables segment accounted for the largest share in the market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

The market for infectious disease diagnostics is divided into immunodiagnostics, polymerase chain reaction (PCR), clinical microbiology, isothermal nucleic acid amplification technology (INAAT), DNA sequencing & NGS, DNA microarrays, and other technologies. In 2020, the immunodiagnostics segment had the largest share. This may be due to the increased use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of immunodiagnostic testing, and the growing practice of automation.

The global infectious disease diagnostics market is divided into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. In 2020, North America became the largest market share in the global epidemiology market. The growth of the North American infectious disease diagnostic market could be attributed to the advanced health care system in the US and Canada, the availability of many of the nation's leading laboratories, and the easy availability of advanced technology.

The major players in the global infectious disease diagnostics market are Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), Roche Diagnostics Ltd. (Switzerland), bioMérieux SA (France), and Danaher Corporation (US).

Revenue Share (%), By Product & Service (2019)
Revenue Share (%), By Technology (2019)
Revenue Share (%), By Disease Type (2019)
Revenue Share (%), By End User (2019)
Revenue Share (%), By Region (2019)

02

Market Overview

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

03

By Disease Type

By Disease Type, The global Infectious Disease Diagnostics Market analysis covers Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hepatitis, Hospital-Acquired Infections (HAIS), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Influenza, Other Infectious Diseases, Tuberculosis (TB).

The Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Hepatitis segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hepatitis: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Hospital-Acquired Infections (HAIS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospital-Acquired Infections (HAIS): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Human Immunodeficiency Virus (HIV) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Human Immunodeficiency Virus (HIV): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Human Papillomavirus (HPV) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Human Papillomavirus (HPV): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Influenza segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Influenza: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Other Infectious Diseases segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Infectious Diseases: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Tuberculosis (TB) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Tuberculosis (TB): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

04

By End User

By End User, The global Infectious Disease Diagnostics Market analysis covers Academic/Research Institutes, Hospital/Clinical Laboratories, Other End Users, Physician Offices, Reference Laboratories.

The Academic/Research Institutes segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Academic/Research Institutes: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Hospital/Clinical Laboratories segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospital/Clinical Laboratories: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Other End Users segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other End Users: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Physician Offices segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Physician Offices: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Reference Laboratories segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Reference Laboratories: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

05

By Product & Service

By Product & Service, The global Infectious Disease Diagnostics Market analysis covers Assays, Kits, & Reagents, Instruments, Services & Software.

The Assays, Kits, & Reagents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Assays, Kits, & Reagents: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Instruments segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Instruments: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Services & Software segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Services & Software: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

06

By Technology

By Technology, The global Infectious Disease Diagnostics Market analysis covers Clinical Microbiology, DNA Microarray, DNA Sequencing & Next-Generation Sequencing (NGS), Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology (INAAT), Other Technologies, Polymerase Chain Reaction (PCR).

The Clinical Microbiology segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Clinical Microbiology: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The DNA Microarray segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

DNA Microarray: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The DNA Sequencing & Next-Generation Sequencing (NGS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

DNA Sequencing & Next-Generation Sequencing (NGS): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Immunodiagnostics segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Immunodiagnostics: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Isothermal Nucleic Acid Amplification Technology (INAAT) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Isothermal Nucleic Acid Amplification Technology (INAAT): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Other Technologies segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Technologies: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Polymerase Chain Reaction (PCR) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Polymerase Chain Reaction (PCR): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

07

By Region

By Region, The global Infectious Disease Diagnostics Market analysis covers Asia Pacific (APAC), Europe, North America, Rest of the World (RoW).

The Asia Pacific (APAC) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Asia Pacific (APAC): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Europe segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Europe: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The North America segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

North America: global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

The Rest of the World (RoW) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Rest of the World (RoW): global Infectious Disease Diagnostics Market Revenue Opportunity (Us$ Mn)

08

Asia-Pacific

Based on the Asia-Pacific, the Infectious Disease Diagnostics Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.